Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Back To Forum List View

Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics

BearDownAZ

Jun 12, 2017 07:36PM

Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics

BearDownAZ

Jun 12, 2017 08:00PM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics

in response to

Re: Another SGLT-2 inhibitor shows cardiovascular benefit in diabetics

BearDownAZ

posted on Jun 12, 2017 08:24PM

Here's the link to the NEJM article just released on the CANVAS cardio outcomes trial: